TickerFactsScreenerDevelopers

LISATA THERAPEUTICS, INC. (LSTA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $7.16M2010: $8.47M2011: $3.94M2012: $13.74M2013: $46.13M2014: $19.17M2015: $20.32M2016: $7.08M2017: $29.16M2018: $10.30M2019: $14.03M2020: $16.51M2021: $24.65M2022: $32.15M2023: $22.59M2024: $16.21M2025: $15.96M$15.96M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$15.96M-1.6%
2024$16.21M-28.3%
2023$22.59M-29.7%
2022$32.15M+30.5%
2021$24.65M+49.3%
2020$16.51M+17.7%
2019$14.03M+36.2%
2018$10.30M-64.7%
2017$29.16M+312.1%
2016$7.08M-65.2%
2015$20.32M+6.0%
2014$19.17M-58.4%
2013$46.13M+235.8%
2012$13.74M+249.1%
2011$3.94M-53.5%
2010$8.47M+18.3%
2009$7.16M—